Nivolumab (PD-1 inhibitor)
Treatment used for 1 condition
Total Trials
14
Total Participants
3K
Avg Effectiveness
70%
Avg Safety Score
45%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.